Who to call at Petros Pharmaceuticals, Inc., and when
Fundz watches for the moments Petros Pharmaceuticals, Inc. starts buying, and tells you who to reach.
- An alert the day Petros Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Petros Pharmaceuticals, Inc., from your own LinkedIn network
Petros Pharmaceuticals, Inc.
The company filed for bankruptcy or receivership. An 8-K is the notice a US public company must file within four business days of a major event.
www.petrospharma.comAI Executive Summary
AI-powered analysis of 8-K filing content
Petros Pharmaceuticals, Inc. entered into a General Assignment for the Benefit of Creditors on September 30, 2026, transferring all assets to PT Liquidation, LLC for liquidation. This represents a formal bankruptcy event indicating the company has ceased operations and cannot continue as a going concern.
Key Takeaways
Company has ceased nearly all operations and declared inability to continue as a going concern
All company assets have been transferred to PT Liquidation, LLC to manage the liquidation process
2 more takeaways
Filing Overview
What This Means
Petros Pharmaceuticals, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.